New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Ten-minute scan enables detection and cure of the most common cause of high blood pressure

Ten-minute scan enables detection and cure of the most common cause of high blood pressure

by Queen Mary, University of LondonCredit: Pixabay/CC0 Public DomainDoctors at Queen Mary University of London and Barts Hospital, and Cambridge University Hospital, have led research using a new
Diabetes & Endocrinology January 28,2024
Ten-minute scan enables detection and cure of the most common cause of high blood pressure

Ten-minute scan enables detection and cure of the most common cause of high blood pressure

by Queen Mary, University of LondonCredit: Pixabay/CC0 Public DomainDoctors at Queen Mary University of London and Barts Hospital, and Cambridge University Hospital, have led research using a new
Diabetes & Endocrinology January 28,2024
Stigmatization takes a major toll on those living with skin diseases across Europe, says study

Stigmatization takes a major toll on those living with skin diseases across Europe, says study

by European Academy of Dermatology and VenereologyFrequencies of the answers to the question ‘When was the diagnosis confirmed?’ in patients with different skin diseases. Credit:Journal of the E
Dermatology January 28,2024
Stigmatization takes a major toll on those living with skin diseases across Europe, says study

Stigmatization takes a major toll on those living with skin diseases across Europe, says study

by European Academy of Dermatology and VenereologyFrequencies of the answers to the question ‘When was the diagnosis confirmed?’ in patients with different skin diseases. Credit:Journal of the E
Dermatology January 28,2024
Previous cancer linked to long term heightened risk of cardiovascular disease

Previous cancer linked to long term heightened risk of cardiovascular disease

by British Medical JournalCredit: Pixabay/CC0 Public DomainCancer survivors may be at long term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk f
Oncology January 28,2024
Previous cancer linked to long term heightened risk of cardiovascular disease

Previous cancer linked to long term heightened risk of cardiovascular disease

by British Medical JournalCredit: Pixabay/CC0 Public DomainCancer survivors may be at long term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk f
Oncology January 28,2024
FDA approves first nonhormonal drug to ease menopause hot flashes

FDA approves first nonhormonal drug to ease menopause hot flashes

by Physician's Briefing StaffThe U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes.The new pill, called Veozah (fezolineta
Diabetes & Endocrinology January 28,2024
FDA approves first nonhormonal drug to ease menopause hot flashes

FDA approves first nonhormonal drug to ease menopause hot flashes

by Physician's Briefing StaffThe U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes.The new pill, called Veozah (fezolineta
Diabetes & Endocrinology January 28,2024
Lymphoid reaction observed in eczema patients receiving dupilumab

Lymphoid reaction observed in eczema patients receiving dupilumab

by Elana GotkineFor adults with atopic dermatitis (AD) receiving dupilumab treatment, a reversible lymphoid reaction (LR) has been observed, which mimics cutaneous T-cell lymphoma (CTCL), according to
Dermatology January 28,2024
Lymphoid reaction observed in eczema patients receiving dupilumab

Lymphoid reaction observed in eczema patients receiving dupilumab

by Elana GotkineFor adults with atopic dermatitis (AD) receiving dupilumab treatment, a reversible lymphoid reaction (LR) has been observed, which mimics cutaneous T-cell lymphoma (CTCL), according to
Dermatology January 28,2024
The gut microbiome's supersized role in shaping molecules in our blood

The gut microbiome's supersized role in shaping molecules in our blood

by Institute for Systems BiologyCredit: Pixabay/CC0 Public DomainScientists from the Institute for Systems Biology (ISB) have shown which blood metabolites are associated with the gut microbiome, gene
Diabetes & Endocrinology January 28,2024
The gut microbiome's supersized role in shaping molecules in our blood

The gut microbiome's supersized role in shaping molecules in our blood

by Institute for Systems BiologyCredit: Pixabay/CC0 Public DomainScientists from the Institute for Systems Biology (ISB) have shown which blood metabolites are associated with the gut microbiome, gene
Diabetes & Endocrinology January 28,2024
Nemolizumab improves symptoms in prurigo nodularis: Clinical trial

Nemolizumab improves symptoms in prurigo nodularis: Clinical trial

by Elana GotkineFor patients with moderate-to-severe prurigo nodularis, nemolizumab improves symptoms, according to a study published in the Oct. 26 issue of theNew England Journal of Medicine.S
Dermatology January 28,2024
Nemolizumab improves symptoms in prurigo nodularis: Clinical trial

Nemolizumab improves symptoms in prurigo nodularis: Clinical trial

by Elana GotkineFor patients with moderate-to-severe prurigo nodularis, nemolizumab improves symptoms, according to a study published in the Oct. 26 issue of theNew England Journal of Medicine.S
Dermatology January 28,2024
Study finds new feature indicative of gastrointestinal tumor recurrence

Study finds new feature indicative of gastrointestinal tumor recurrence

by CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers from the University of Colorado Anschutz Medical Campus have identified a new feature indicative of the chance of recurre
Oncology January 28,2024
Study finds new feature indicative of gastrointestinal tumor recurrence

Study finds new feature indicative of gastrointestinal tumor recurrence

by CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers from the University of Colorado Anschutz Medical Campus have identified a new feature indicative of the chance of recurre
Oncology January 28,2024
The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes

The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes

by CIC bioGUNEProteomic analyses reveal changes in hACE2 mouse hepatocytes after infection with pseudotyped viral particles expressing the spike of SARS-CoV-2. a Volcano plot showing the 354 different
Diabetes & Endocrinology January 28,2024
The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes

The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes

by CIC bioGUNEProteomic analyses reveal changes in hACE2 mouse hepatocytes after infection with pseudotyped viral particles expressing the spike of SARS-CoV-2. a Volcano plot showing the 354 different
Diabetes & Endocrinology January 28,2024
Study finds that laser epilation reduces risk of recurrence of pilonidal disease

Study finds that laser epilation reduces risk of recurrence of pilonidal disease

by Nemours Children's Health SystemCredit: CC0 Public DomainLaser epilation, commonly known as laser hair removal, reduced the risk of recurrence in patients with pilonidal disease, an inflam
Dermatology January 28,2024
Study finds that laser epilation reduces risk of recurrence of pilonidal disease

Study finds that laser epilation reduces risk of recurrence of pilonidal disease

by Nemours Children's Health SystemCredit: CC0 Public DomainLaser epilation, commonly known as laser hair removal, reduced the risk of recurrence in patients with pilonidal disease, an inflam
Dermatology January 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com